Sector valuations Jiangsu Hengrui Pharmaceuticals Co.,Ltd
Equities
600276
CNE0000014W7
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55.56 CNY | +3.43% |
|
-1.77% | -6.73% |
| 03-05 | Merck to expand China investment, Xinhua reports | RE |
| 03-05 | Hengrui Pharmaceuticals Obtains Nod for Lung Cancer Combo Drug Trials | MT |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 42.79x | 6.04x | 1.43x | 9.97x | 33.79x | 38.68x | 0.47% | 53.42B | ||
| 29.11x | 17.94x | 0.6x | 10.96x | 22.02x | 23.36x | 0.67% | 885B | ||
| 24.47x | 6.62x | -2.24x | 5.94x | 16.17x | 17.86x | 2.2% | 579B | ||
| 24.99x | 72.15x | 0.09x | 6.83x | 13.71x | 14.06x | 3.01% | 407B | ||
| 18.18x | 6.35x | 1.07x | 4.48x | 11.08x | 12.6x | 2.95% | 350B | ||
| 21.57x | 6.38x | 11.83x | 5.8x | 14.34x | 15.34x | 2.79% | 302B | ||
| 24.42x | 5.55x | 1.13x | 5.09x | 14.1x | 15.13x | 1.71% | 301B | ||
| 27.07x | 5.06x | -0.66x | 4.75x | 14.84x | 17.52x | 2.92% | 286B | ||
| 24.86x | 16.7x | 5.57x | 6.31x | 11.22x | 14.33x | 2.72% | 199B | ||
| 19.95x | 6.76x | 3.12x | 6.07x | 10.98x | 12.93x | 2.26% | 179B | ||
| 11.71x | 5.02x | -1.45x | 4.25x | 8.78x | 10.27x | 4.35% | 171B | ||
| 12.65x | 1.69x | 0.22x | 3.2x | 7.65x | 9.07x | 6.5% | 154B | ||
| 12.05x | 5.27x | 0.27x | 3.17x | 8.52x | 9.15x | 4.17% | 123B | ||
| 26.04x | 5.12x | 1.8x | 7.8x | 17.52x | 18.1x | -.--% | 116B | ||
| 12.79x | 4.34x | 0.99x | 2.77x | 8.02x | 9.2x | 3.4% | 109B | ||
| 11.7x | 1.18x | 5.81x | 2.2x | 7.29x | 7.87x | 5.53% | 107B | ||
| 36.86x | 7.97x | 3.51x | 11.93x | 23.45x | 25x | 2.64% | 100B | ||
| 51.29x | 1.28x | 0.82x | 2.85x | 10.57x | 30.03x | 3.52% | 57B | ||
| 21.41x | 2.04x | 1.76x | 3.71x | 14.69x | 16.44x | 1.88% | 44.97B | ||
| 47.82x | 19.04x | 0.25x | 7.01x | 33.57x | 34.83x | -.--% | 42.53B | ||
| Average | 25.09x | 10.12x | 1.80x | 5.75x | 15.12x | 17.59x | 2.68% | 228.33B | |
| Weighted average by Cap. | 24.00x | 14.44x | 1.39x | 6.54x | 15.24x | 16.92x | 2.42% |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















